P&G (NYSE: PG) HR chief sells 12,827 shares after option exercise
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Procter & Gamble’s Chief Human Resources Officer, Purushothaman Balaji, reported an option exercise and share sale on February 11, 2026. He exercised a stock option for 12,827 shares of common stock at an exercise price of $91.07 per share.
On the same day, he sold 12,827 common shares in an open-market transaction at a weighted average price of $160.3093 per share, as disclosed in the footnote. Following these transactions, he held 12,638.8004 shares directly and 5,223.363 shares indirectly through a retirement plan trustee.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 12,827 shares ($2,056,287)
Net Sell
4 txns
Insider
Purushothaman Balaji
Role
Chief Human Resources Officer
Sold
12,827 shs ($2.06M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 12,827 | $0.00 | -- |
| Exercise | Common Stock | 12,827 | $91.07 | $1.17M |
| Sale | Common Stock | 12,827 | $160.3093 | $2.06M |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 shares (Direct);
Common Stock — 25,465.8 shares (Direct);
Common Stock — 5,223.363 shares (Indirect, By Retirement Plan Trustee)
Footnotes (1)
- Weighted average price of the shares sold. The price range was $160.30 to $160.36. Full information regarding the number of shares sold at each separate price available upon request. Reflects adjustment to PST through December 31, 2025.
FAQ
What did PG executive Purushothaman Balaji report in this Form 4?
He reported exercising stock options and selling shares. On February 11, 2026, Balaji exercised options for 12,827 Procter & Gamble common shares, then sold 12,827 shares in an open-market transaction, and updated his direct and indirect share holdings accordingly.
What type of derivative security did the PG executive exercise?
He exercised a stock option (right to buy) for 12,827 shares. The option carried a $91.07 exercise price, was originally granted on February 28, 2020, and was scheduled to expire on February 26, 2027, before being fully exercised in this transaction.